Functional fingerprinting of human mesenchymal stem cells using high-throughput RNAi screening

被引:0
|
作者
Gerrit Erdmann
Michael Suchanek
Patrick Horn
Fabian Graf
Christian Volz
Thomas Horn
Xian Zhang
Wolfgang Wagner
Anthony D. Ho
Michael Boutros
机构
[1] Medical Faculty Mannheim,German Cancer Research Center (DKFZ), Division Signaling and Functional Genomics and Heidelberg University, Department of Cell and Molecular Biology
[2] Heidelberg University,Department of Medicine V
[3] Helmholtz Institute for Biomedical Engineering,RWTH Aachen Medical School
来源
Genome Medicine | / 7卷
关键词
Human Bone Marrow; Fibroblast Cell Line; Primary Fibroblast; Cell Cycle Profile; Laser Scanning Cytometry;
D O I
暂无
中图分类号
学科分类号
摘要
Mesenchymal stem cells (MSCs) are promising candidates for cellular therapies ranging from tissue repair in regenerative medicine to immunomodulation in graft versus host disease after allogeneic transplantation or in autoimmune diseases. Nonetheless, progress has been hampered by their enormous phenotypic as well as functional heterogeneity and the lack of uniform standards and guidelines for quality control. In this study, we describe a method to perform cellular phenotyping by high-throughput RNA interference in primary human bone marrow MSCs. We have shown that despite heterogeneity of MSC populations, robust functional assays can be established that are suitable for high-throughput and high-content screening. We profiled primary human MSCs against human fibroblasts. Network analysis showed a kinome fingerprint that differs from human primary fibroblasts as well as fibroblast cell lines. In conclusion, this study shows that high-throughput screening in primary human MSCs can be reliably used for kinome fingerprinting.
引用
收藏
相关论文
共 50 条
  • [1] Exploring the mesenchymal stem cell niche using high throughput screening
    Ghaemi, Soraya Rasi
    Harding, Frances J.
    Delalat, Bahman
    Gronthos, Stan
    Voelcker, Nicolas H.
    BIOMATERIALS, 2013, 34 (31) : 7601 - 7615
  • [2] Human mesenchymal stem cells lose their functional properties after paclitaxel treatment
    Muenz, Franziska
    Perez, Ramon Lopez
    Thuy Trinh
    Sisombath, Sonevisay
    Weber, Klaus-Josef
    Wuchter, Patrick
    Debus, Juergen
    Saffrich, Rainer
    Huber, Peter E.
    Nicolay, Nils H.
    SCIENTIFIC REPORTS, 2018, 8
  • [3] Human Mesenchymal Stem Cells in Cancer Therapy
    Kalkan, R.
    Serakinci, N.
    CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2016, 26 (01): : 41 - 48
  • [4] EFFECT OF PROGESTERONE ON HUMAN MESENCHYMAL STEM CELLS
    Kyurkchiev, Dobroslav S.
    Ivanova-Todorova, Ekaterina
    Kyurkchiev, Stanimir D.
    VITAMINS AND HORMONES: STEM CELL REGULATORS, 2011, 87 : 217 - 237
  • [5] Phenotypic and Functional Characterization of Mesenchymal Stem Cells from Chorionic Villi of Human Term Placenta
    Abumaree, M. H.
    Al Jumah, M. A.
    Kalionis, B.
    Jawdat, D.
    Al Khaldi, A.
    AlTalabani, A. A.
    Knawy, B. A.
    STEM CELL REVIEWS AND REPORTS, 2013, 9 (01) : 16 - 31
  • [6] High-throughput screening paradigms in ecotoxicity testing: Emerging prospects and ongoing challenges
    Wlodkowic, Donald
    Jansen, Marcus
    CHEMOSPHERE, 2022, 307
  • [7] Isolation, cultivation, and characterization of human mesenchymal stem cells
    Mushahary, Dolly
    Spittler, Andreas
    Kasper, Cornelia
    Weber, Viktoria
    Charwat, Verena
    CYTOMETRY PART A, 2018, 93A (01) : 19 - 31
  • [8] Functional heterogeneity of mesenchymal stem cells: Implications for cell therapy
    Phinney, Donald G.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2012, 113 (09) : 2806 - 2812
  • [9] Human Mesenchymal Stem Cells for Spinal Cord Injury
    Alishahi, Masoumeh
    Anbiyaiee, Amir
    Farzaneh, Maryam
    Khoshnam, Seyed E.
    CURRENT STEM CELL RESEARCH & THERAPY, 2020, 15 (04) : 340 - 348
  • [10] Cisplatin radiosensitizes radioresistant human mesenchymal stem cells
    Ruehle, Alexander
    Perez, Ramon Lopez
    Glowa, Christin
    Weber, Klaus-Josef
    Ho, Anthony D.
    Debus, Juergen
    Saffrich, Rainer
    Huber, Peter E.
    Nicolay, Nils H.
    ONCOTARGET, 2017, 8 (50) : 87809 - 87820